We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
ANI Pharmaceuticals has submitted a prior approval supplement (PAS) to the Endocrinology Division at the FDA for re-commercialization of Purified Cortrophin® Gel (Repository Corticotropin Injection USP) (80 U/mL).
ANI Pharmaceuticals, Inc.today announced that it has received approval from FDA of its Abbreviated New Drug Application ("ANDA") for Morphine Sulfate Oral Solution 10mg/5mL, 20mg/5mL and 100mg/5mL.
ANI Pharmaceuticals, Inc. today announced that it has received $ 45 million in cash from the NDA and AstraZeneca Inc.'s ATACAND®, ATACANDHCT®, ARIMIDEX®, and CASODEX® in the United States